Skip to main content
Caplight Logo









Xpress Genomics

Xpress Genomics

Private
SolnaHealthcare & Life Scienceshttps://xpress-genomics.com/

Company Overview

Xpress Genomics is a biotechnology company that provides scalable and high-quality genomics services, specializing in single-cell RNA-sequencing for researchers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

genomics servicessingle-cell RNA sequencingscRNA-seqfull-length scRNA-seqcontract research organizationCROsequencing as a servicenext-generation sequencingNGShigh-throughput sequencingspatial transcriptomicsbulk RNA sequencingbioinformatics servicesproteomics servicesOlink service providerATAC-seqepigenomics servicesNGS library preparation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Xpress Genomics Comparables

Compare Xpress Genomics with similar companies based on industry and business-model similarity.

Xpress Genomics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Single Cell Discoveries
86%
SingulOmics Corporation
84%
Admera Health
83%

Xpress Genomics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Xpress Genomics Filings

Explore SEC and related filing metadata, where available.

Xpress Genomics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Xpress Genomics's valuation, stock price, and market status.

Is Xpress Genomics a public or private company?

Xpress Genomics is a private company.

What is the current stock price of Xpress Genomics?

Xpress Genomics is a private company with no public stock price. No recent secondary market data is available.

How much is Xpress Genomics worth (valuation)?

Valuation information for Xpress Genomics is not publicly available.

Can I buy Xpress Genomics stock?

Xpress Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Xpress Genomics's last funding round?

Funding round information for Xpress Genomics is not publicly available.

Who are the main investors in Xpress Genomics?

Investor information for Xpress Genomics is not publicly disclosed.

Will Xpress Genomics IPO soon?

No public IPO plans have been announced for Xpress Genomics.

How can I track Xpress Genomics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Xpress Genomics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSolna
Year Founded2022
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?